North America XI Ltd Kkr serves as Executive at PRA Health Sciences, Inc., where they oversee executive responsibilities. Since joining the company, North America XI Ltd Kkr has executed 6 insider transactions totaling $1.7B, demonstrating a bearish approach to their equity position. Their most recent transaction on May 23, 2024 involved selling 17,500,000 shares valued at $218.4M.
North America XI Ltd Kkr currently holds 33,133,123 shares of PRA Health Sciences, Inc. (PRAH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, North America XI Ltd Kkr has been a net seller of PRAH stock. They have purchased $0 and sold $1.7B worth of shares.
North America XI Ltd Kkr's most recent insider trade was on May 23, 2024, when they sold 17,500,000 shares at $12.48 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| May 13, 2021 | IR | $724.9M | Sale | 14,924,081 | $48.57 | Discretionary |
| Nov 2, 2018 | GDI | $0 | Other | 50,274 | $N/A | Discretionary |
| Nov 2, 2018 | GDI | $513.2M | Sale | 20,000,000 | $25.66 | Discretionary |
| Mar 8, 2016 | PRAH | $204.1M | Sale | 4,829,981 | $42.26 | Discretionary |